ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Cell Phone SMS to Improve Adherence to ART in HIV Positive Young Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02301507
Recruitment Status : Completed
First Posted : November 26, 2014
Last Update Posted : May 23, 2017
Sponsor:
Information provided by (Responsible Party):
Tanvir K. Bell, MD, The University of Texas Health Science Center, Houston

Brief Summary:

There has been increasing use of technology in delivery of healthcare and increasing use of cellular phone and text messaging services to help with various healthcare related issues including but not limited to medication adherence and clinic attendance. Mobile phones technology has been used for healthcare delivery and prevention strategies such as smoking cessation. In the present era, cell phones have become part of daily life for most people even among those in lower economic groups. There have also been several studies looking at cell phone text messaging services to improve adherence to ART among HIV infected subjects but no studies have so far been done in HIV infected young women to help retention and adherence to care. The overall goal of this study is to evaluation of the impact of texting intervention to improve adherence to care and treatment in HIV infected young women.

Study Hypothesis:

Text message intervention will improve adherence to ART in HIV infected young women.


Condition or disease Intervention/treatment Phase
HIV Infection Behavioral: cell phone SMS text messaging Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 7 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Evaluation of Texting Intervention to Improve Adherence to Antiretroviral Therapy (ART) in Young Women Infected With Human Immunodeficiency Virus (HIV)
Study Start Date : November 2014
Actual Primary Completion Date : August 2015
Actual Study Completion Date : July 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS

Arm Intervention/treatment
Experimental: SMS (texting) Arm
texts received
Behavioral: cell phone SMS text messaging
This study will utilize mobile texting services to send text messages to enrolled subjects on a weekly basis. The text would convey messages that promote better awareness and knowledge on HIV and its treatment, reminders for medication adherence and clinic appointments. The text content would also be customized based on individual subject requirements. English will be used in texting. We would also assess the subjects for traditional demographic items (e.g., age, marital status, education, number/age of other children, employment, and religion), and potential environmental barriers (e.g., transportation and childcare).




Primary Outcome Measures :
  1. Improve adherence to care and treatment in HIV infected young women. The outcome measure will be assessed by capturing kept medical appointments. [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. assess improvements in stigma and depression in HIV infected women. The outcome measure will be assessed by questionaires. [ Time Frame: 3 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. HIV-infected women who have been newly diagnosed within the past 1 year or who are just entering into care at Thomas Street Health Center.
  2. Subjects must be 18 years or older.
  3. Subjects must have cell phones with texting capability.
  4. Ability to speak, read, or understand English or Spanish.
  5. Must be willing and able to respond to text messages.

Exclusion Criteria:

1. Women who are unable to speak, read, or understand English or Spanish


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02301507


Locations
United States, Texas
Thomas Street Health Center
Houston, Texas, United States, 77009
Sponsors and Collaborators
The University of Texas Health Science Center, Houston

Responsible Party: Tanvir K. Bell, MD, Associate Professor of Medicine, The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier: NCT02301507     History of Changes
Other Study ID Numbers: HSC-MS-14-0692
First Posted: November 26, 2014    Key Record Dates
Last Update Posted: May 23, 2017
Last Verified: May 2017

Additional relevant MeSH terms:
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases